Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CHRS - Coherus BioSciences, Inc.
69.6 M
LAST VALUE
15.83%
2 YEAR CAGR
-7.97%
5 YEAR CAGR
21.47%
10 YEAR CAGR